Christian Verger

Christian Verger

Auto-generated profile, based on publicly available information

Christian Verger

RDPLF, Pontoise (France)

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1996 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
ICIrène Ceballos-Picot
Irène Ceballos-Picot
VWVéronique Witko-Sarsat
Véronique Witko-Sarsat
MMMansouria Merad-Boudia
Mansouria Merad-Boudia
ANAnh Thu Nguyen
Anh Thu Nguyen
MTMarc Thévenin
Marc Thévenin
BDBéatrice Descamps-Latscha
Béatrice Descamps-Latscha

15 January 1995 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
BDB Descamps-Latscha
B Descamps-Latscha
AHA Herbelin
A Herbelin
ANA T Nguyen
A T Nguyen
PRP Roux-Lombard
P Roux-Lombard
JZJ Zingraff
J Zingraff
JDJ-M Dayer
J-M Dayer
Patients with end-stage renal disease present an immunodeficiency that paradoxically coexists with activation of most immunocompetent cells, and the roles of chronic uremia and maintenance dialysis are poorly understood. We determined circulating levels of IL-1 beta and IL-1Ra, TNF-alpha and its soluble receptors (TNF-sR55 and TNF-sR75), and activation markers of T cells (soluble CD25), B cells (soluble CD23), and monocytes (neopterin) in a large cohort of undialyzed patients at various stages of chronic renal failure and in dialyzed patients on maintenance hemodialysis or chronic peritoneal dialysis. The progression of uremia was associated with a gradual increase in soluble CD25, CD23, and especially neopterin levels. Although IL-1 beta could not be detected, IL-1Ra levels were significantly increased from the earliest stage of renal failure. Plasma levels of TNF-alpha, TNF-sR55, and TNF-sR75 progressed with the severity of renal failure and correlated with soluble CD25, CD23, and neopterin levels, whereas IL-1Ra levels correlated exclusively with TNF-sR55 levels. Compared with undialyzed patients, levels of IL-1 beta were higher in patients on maintenance hemodialysis, whereas those of IL-1Ra were lower and decreased further at the end of dialysis sessions. In contrast, both TNF-sR55 and TNF-sR75 levels were significantly higher than in undialyzed patients and increased further at the end of dialysis sessions in the absence of an increase of TNF-alpha. Such an imbalance between cytokines and their inhibitors may play a pivotal role in the multifaceted process of immune dysfunction.

24 February 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
WBWim Van Biesen
Wim Van Biesen
JWJohn D. Williams
John D. Williams
ACAdrian C. Covic
Adrian C. Covic
SFStanley Fan
Stanley Fan
Kathleen ClaesKathleen Claes
Kathleen Claes
OGon behalf of the EuroBCM study group
on behalf of the EuroBCM study group
Euvolemia is an important adequacy parameter in peritoneal dialysis (PD) patients. However, accurate tools to evaluate volume status in clinical practice and data on volume status in PD patients as compared to healthy population, and the associated factors, have not been available so far. We used a bio-impedance spectroscopy device, the Body Composition Monitor (BCM) to assess volume status in a cross-sectional cohort of prevalent PD patients in different European countries. The results were compared to an age and gender matched healthy population. Only 40% out of 639 patients from 28 centres in 6 countries were normovolemic. Severe fluid overload was present in 25.2%. There was a wide scatter in the relation between blood pressure and volume status. In a multivariate analysis in the subgroup of patients from countries with unrestricted availability of all PD modalities and fluid types, older age, male gender, lower serum albumin, lower BMI, diabetes, higher systolic blood pressure, and use of at least one exchange per day with the highest hypertonic glucose were associated with higher relative tissue hydration. Neither urinary output nor ultrafiltration, PD fluid type or PD modality were retained in the model (total R2 of the model = 0.57). The EuroBCM study demonstrates some interesting issues regarding volume status in PD. As in HD patients, hypervolemia is a frequent condition in PD patients and blood pressure can be a misleading clinical tool to evaluate volume status. To monitor fluid balance, not only fluid output but also dietary input should be considered. Close monitoring of volume status, a correct dialysis prescription adapted to the needs of the patient and dietary measures seem to be warranted to avoid hypervolemia.

1 June 1983 in Kidney International
Verified
Journal Article
Closed access
CVChristian Verger
Christian Verger
ALAlan Luger
Alan Luger
HMHarold L. Moore
Harold L. Moore
KNKarl D. Nolph
Karl D. Nolph

1 November 2006 in Kidney International
Verified
Journal Article
Closed access
CVC. Verger
C. Verger
JRJ.-P. Ryckelynck
J.-P. Ryckelynck
MDM. Duman
M. Duman
GVG. Veniez
G. Veniez
TLT. Lobbedez
T. Lobbedez
OMO. Moranne
O. Moranne

1 April 2002 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
PDF file
JPJoerg Plum
Joerg Plum
SGStella Gentile
Stella Gentile
CVChristian Verger
Christian Verger
RBReinhart Brunkhorst
Reinhart Brunkhorst
UBUdo Bahner
Udo Bahner
JFJosé C.Divino Filho
José C.Divino Filho